Glympse Bio pulls in $46.7m Series B
Cambridge, Massachusetts-based Glympse Bio, a biotechnology company, has raised $46.7 million in Series B financing.
Cambridge, Massachusetts-based Glympse Bio, a biotechnology company, has raised $46.7 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
